| マレーシア | トルコ | オーストリア | |
| 高密度焦点式超音波焼灼術 | から $7,200 | から $4,000 | から $12,000 |
| 高周波焼灼術 | から $4,800 | から $6,300 | から $15,000 |
| 骨髄移植術 | から $38,000 | から $36,000 | から $140,000 |
| 陽子線治療 | から $38,000 | から $70,000 | から $80,000 |
| 腹腔鏡下腎摘出術 | から $9,500 | から $12,830 | から $15,000 |
Bookimedは腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。腫瘍科治療の旅路でお一人になることはありません。
The best oncologist in Malaysia specialises in the patient's cancer type and works within a multidisciplinary team. Private hospitals in Kuala Lumpur and Selangor offer expert oncologists supported by tumour boards for collective treatment decisions. Seeking a second opinion and good communication is vital for personalised care.
Bookimed Expert Insight: Malaysian private hospitals with multidisciplinary tumour boards deliver faster, coordinated care. These tumour boards improve treatment quality by reviewing cases collectively. Though specific oncologist names are unavailable, private centres in Kuala Lumpur and Selangor offer this advantage. Patients avoid public facilities, where oncologist shortages cause delays.
Patient consensus: Patients appreciate how hospital tumour boards team up specialists for tailored treatment. Many highlight quicker appointments and clear support from private Malaysian hospitals. Australians note the access to second opinions and dedicated palliative care as reassuring during cancer treatment. Communication and feeling involved are common positives.
Malaysian hospitals offer advanced oncology technologies like CyberKnife radiosurgery and immunotherapy with Keytruda. They provide precise radiotherapy and radiofrequency ablation to target tumours. AI-driven diagnosis and targeted therapy personalise treatment for better outcomes with fewer side effects.
Bookimed Expert Insight: Private Malaysian hospitals tend to update oncology technologies faster than public ones. Many offer packages that include immunotherapy, CyberKnife, and precise radiotherapy under one roof. This setup cuts waiting times and keeps care consistent. Australian patients should note technology access varies widely between centres.
Patient Consensus: Patients appreciate Malaysia’s advanced tech, especially AI-assisted diagnosis and targeted therapies. Private hospitals make treatment smoother and faster. Many note the care quality matches Singapore’s, with less wait and clear communication.
Cancer treatment options in Malaysia include surgery, chemotherapy, radiotherapy, immunotherapy, targeted therapy, and hormone therapy. Surgery and chemotherapy are common first steps. Immunotherapy and targeted therapy offer modern precision but at a higher cost. Both public and private hospitals provide these treatments.
Bookimed Expert Insight: Private hospitals in Malaysia offer faster access to immunotherapy and diagnostics. Public hospitals provide affordable chemotherapy but with longer waits. Patients often combine surgery with targeted drugs or radiation for better results. Confirm waiting times and specialist availability due to limited surgical theatres in government centres.
Patient consensus: Patients in Malaysia value quick surgery options and report noticeable tumour shrinkage from radiotherapy. Many highlight the importance of diet and exercise during treatment. Chemotherapy side effects like fatigue are common but manageable with good support.
Cancer treatment in Malaysia affects quality of life through physical side effects and psychological stress. Support like pharmacist counselling improves mental health during chemotherapy. After treatment, survivors often enjoy improved survival with ongoing care focused on normal living and long-term well-being.
Bookimed Expert Insight: Malaysian private clinics speed up diagnosis and start chemo earlier, which helps patients keep their quality of life better than waiting in public hospitals. While public facilities offer strong expertise, long waits may lower comfort during early treatment. Combining fast access with pharmacist counselling or targeted support improves patient mental and physical well-being.
Patient Consensus: Patients say Malaysia’s affordable care helps them avoid financial stress during treatment. They note private centres shorten waiting times and start treatment faster, which keeps energy and mood higher. Many appreciate that after therapy, they can return to everyday activities thanks to effective care and ongoing support.
Second opinions on cancer diagnosis and treatment plans are widely available in Malaysia. Patients can access thorough reviews from private and public specialists. Malaysian care often offers faster, more affordable options to compare with current plans.
Bookimed Expert Insight: Malaysian hospitals combine public coverage with private speed, giving patients flexible second-opinion options. Since many clinics offer remote evaluations, patients can compare treatment plans without rushing travel. Also, oncology centres cover modern therapies like CyberKnife and bone marrow transplantation, broadening choices beyond initial diagnoses.
Patient consensus: Patients value Malaysia for clear second opinions that explain all options well. Many note shorter waiting times and easier access to specialists compared with nearby countries. Australians say doctors listen carefully, and remote consultations help filter decisions before flying.
Oncology teams in Malaysia commonly coordinate with Australian doctors for continuity of care. Private hospitals often provide detailed medical summaries and share reports. Communicating early about follow-up allows clear contact routes to local GPs or specialists.
Bookimed Expert Insight: Malaysian centres with international patient departments offer smoother report sharing. These units help connect doctors across countries and speed up data exchange. Clinics without such services often require patients to manage information transfer themselves. For example, hospitals aligned with global networks tend to have clearer communication pathways for Australians undergoing oncology treatments in Malaysia.
Patient consensus: Patients say it’s important to ask Malaysian teams to share all biopsy and scan results with their Aussie doctors. Bringing physical and digital reports from Australia helps avoid delays. Cancer patients note communication isn’t automatic, so clearing this up early makes follow-up easier back home.
Cancer treatment in Malaysia does not always need to start immediately. Timing depends on cancer type and urgency, with some cancers requiring fast action and others allowing wait time for planning.
Bookimed Expert Insight: Private hospitals in Malaysia typically speed up cancer treatment starts. Clinics often arrange scans and specialist visits within days. This contrasts with public hospitals, where insurance approval and longer waits delay treatment. Australians considering care can expect faster timelines when choosing private providers in Selangor and George Town.
Patient Consensus: Patients in Malaysia say private centres feel faster and more organised. They note waiting times may stretch in public hospitals, but cancer care is thorough once treatment begins. Many highlight helpful social workers who ease subsidy and insurance issues during the process.
マレーシアには、 価格帯やサービスレベルが異なる様々なホテルがあります。ほとんどの観光客は、食事付きの4つ星または5つ星ホテルを選びます。これらのホテルは、豊富な食事オプション、広々とした手入れの行き届いた敷地、子供から大人まで楽しめるエンターテイメントなど、快適な滞在に必要なすべてを提供しています。中には、宿泊客が無料で利用できるウォーターパークを併設しているホテルもあります。予算重視の旅行者は、ハーフボードまたは食事なしの経済的な3つ星ホテルを予約することもできます。
マレーシアは年間を通して安定した気候を誇ります。しかし、旅行に最適な時期は12月、2月、3月です。この時期は、豪雨の時期や、クリスマス、正月、旧正月といった観光シーズンのピークを避けることができるため、最も好ましい時期と言えるでしょう。
米国および欧州からの患者はマレーシアへの渡航にビザは必要ありませんが、滞在期間は90日間に制限されています。治療に90日以上かかる場合は、自国のマレーシア大使館に連絡して長期滞在ビザの要件についてご相談ください。
マレーシアへの渡航ビザには、 いくつかの書類が必要です。必要な書類は、出発予定日の90日前から提出できます。必要な書類は以下のとおりです。
| 通貨 | マレーシアリンギット(MYR)(米ドルも可) |
| 旅行に最適な時期 | 12月~2月 |
| 言語 | マレー語 |
| ビザ | 米国および欧州からの患者を除き、必須。 |
| ヨーロッパとの時差 | 6時間 |
| アメリカとの時差 | 12時 |
| 資本 | クアラルンプール |
| 医療ツーリズムセンター | クアラルンプール |
| 人気のリゾート | ブンガ ラヤ、パンコール ラウト、シャングリラ |
マレーシアの医療は飛躍的に発展している。病院サービスは保健省が監督しており、同省は国内の医療の質を向上させ、国内外でその発展を促進している。
マレーシア国内には約400の医療施設があり、国内外の患者を受け入れている。私立病院はマレーシア私立病院協会によって認定されている。 マレーシアの医療センターの88%がISO認証を取得しており、 200の私立病院のうち16がJCI認証を取得している(比較として、 ドイツにはJCI認証を取得している施設は1つしかない)。
マレーシアは、優れた医療水準と高度な資格を持つ医師のおかげで、医療ツーリズムの目的地として有名です。 マレーシアの専門医の90%は、英国、米国、オーストラリアで研修を受けています。